QUEBEC CITY, March 16 /PRNewswire-FirstCall/ - Aeterna
Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will
announce its fourth quarter and full year 2010 financial and
operating results on Tuesday, March 22,
2011. The Company will host a conference call and webcast to
discuss these results later that same day at 2:00 p.m., Eastern Time.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Newsroom" section, or by
telephone using the following numbers: in Canada, 514-807-8791 or 416-644-3426, outside
Canada, 800-731-5319. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development
company currently investigating potential treatments for various
cancers including colorectal, ovarian, endometrial cancer and
multiple myeloma. The Company's innovative approach of
"personalized medicine" means tailoring treatments to a patient's
specific condition and to unmet medical needs. Aeterna Zentaris'
deep pipeline is drawn from its proprietary discovery unit
providing the Company with constant and long-term access to
state-of-the-art therapeutic options. For more information please
visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.